Construction and Evaluation of an Educational Product: “HPV: Concept and Prevention”

Self Cite

The Human Papillomavirus (HPV) is responsible for almost 99% of cervical cancers. Cervical cancer is a public health problem, being the fourth most common type of tumor among women worldwide and the third most common cancer among women in Brazil. It is known that cervical cancer is one of the most easily preventable forms of cancer, as there is a highly effective vaccine against HPV, however, morbidity and mortality rates related to human papillomavirus are still frightening, especially in less developed countries. Low vaccination adherence rates, especially the second dose, are probably a reflection of the lack of knowledge about this virus, its clinical repercussions, and the vaccine. A clinical trial was carried out in a higher education institution in Alagoas (Brazil), with students of the medical course to whom a validated questionnaire was applied on HPV in the virtual environment (google forms). Data collection was carried out throughout the month of May of the year 2023. It was shown that the knowledge of medical students about the human papillomavirus was less than what would be desired for future doctors. The alert for the acute need to assess health illiteracy is clear, especially regarding cancer that can be prevented by a highly effective vaccine.

Section: Discussionmentioning

confidence: 99%

Evaluation and Comparison of Medicine Students’ Knowledge about HPV

Oliveira,

Barbosa,

Oliveira

et al. 2023

Self Cite

“…As the providers' recommendation is among the strongest predictors of successful vaccination among adolescents, better education and clarification of national guidelines for providers administering HPV vaccination are essential to optimize infection prevention and associated diseases [15]. Not only do providers have low knowledge about HPV, but it has been verified in a before-and-after clinical trial in order to assess the prior knowledge of medical students about HPV; the percentage of correct answers was 45.6% showing limited knowledge on the subject [24].…”

Section: Discussionmentioning

confidence: 99%

HPV Vaccine: Integrative Review of National and International Guidelines

Filho¹,

Rocha²,

Bacha³

et al. 2022

HPV (Human Papillomavirus) is an adenovirus of the Papillomaviridae family with approximately 200 subtypes (subdivided into low and high oncogenic risk groups), responsible for almost 99% of cervical cancers. Worldwide, there are more than 570,000 new cases and more than 311,000 women die each year from cervical cancer; for Brazil, the estimate is of more than 16,000 new cases per year. It is known that cervical cancer is one of the most easily preventable forms of cancer, as there is a highly effective vaccine against HPV. However, the morbidity and mortality rates correlated with human papillomavirus are still concerning, especially in less developed countries. In 2020, the WHO (World Health Organization) presented three goals to achieve by 2030 the worldwide extermination of cervical cancer; among these goals is vaccination. Is the world preparing for this battle? The present work is an integrative review, comparing national and international guidelines for HPV vaccination published in the last five years in the consulted databases, using the descriptors "cervical cancer", "prevention" and "guideline" and the boolean operator "and", from which nine articles were selected. The study made it possible to compare international and national guidelines for vaccination against HPV, showing that developed countries implemented the HPV vaccine longer ago and follow the WHO recommendations more rigorously and effectively than underdeveloped or developing countries. Adopting a single dose as a strategy, as suggested by the WHO in April 2022, could be an important step towards increasing coverage and providing protection for a greater number of girls who do not have access to HPV immunization.

“…The knowledge and vaccination against HPV are low among university students, demonstrating that greater knowledge is directly associated with greater acceptance of the vaccine [15]. Too Bacha et al verified in a before-and-after clinical trial in order to assess the prior knowledge of medical students about HPV; the percentage of correct answers was 45.6% showing limited knowledge of the subject [2]. In summary, Figure 2 shows the timeline of the most significant changes that occurred in vaccination against HPV in Brazil.…”

Section: Healthmentioning

confidence: 99%

“…It is worth mentioning that cervical cancer is a disease of slow and silent development, and may be asymptomatic in the initial phase, or with precursor lesions, and evolve after 15 to 20 years [2]. However, cervical cancer still has high incidence and mortality rates, especially in less developed countries [2].…”

Section: Introductionmentioning

confidence: 99%

Current HPV Vaccination Strategies in Brazil

Filho¹,

Rocha²,

Bacha³

et al. 2023

Self Cite

Cervical cancer is one of the most preventable and treatable malignancies, however, it still has high incidence and mortality rates, especially in less developed countries. For Brazil, the estimate is more than 16,000 new cases and more than 6000 deaths annually. Despite this, vaccines against HPV (responsible for cervical cancer) are effective and promote a significant decrease in infections and neoplastic lesions of the cervix.